Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuraxial Morphine for Prevention of Postdural Puncture Headache
NCT02473276Phase 4Completed
- Sponsor
- Columbia University
- Start
- Sep 2015
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of morphine in post-dural puncture headache (PDPH), sponsored by Columbia University. Started Sep 2015; status: completed.
02
Drugs
morphine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT02473276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473276.